Literature DB >> 16573239

The ins and outs of intracellular peptides and antigen presentation by MHC class I molecules.

T Groothuis1, J Neefjes.   

Abstract

MHC class I molecules present small intracellular generated fragments to the outside surveying immune system. This is the result of a series of biochemical processes involving biosynthesis, degradation, translocation, intracellular transport, diffusion, and many more. Critical intermediates and end products of this cascade of events are peptides. The peptides are generated by the proteasome, degraded by peptidases unless transported into the ER where another peptidase and MHC class I molecules are waiting. Unless peptides bind to MHC class I molecules, they are released from the ER and enter the cytoplasm by a system resembling the ERAD pathway in many aspects. The cycle of peptides over the ER membrane with the proteasome at the input site and peptidases or MHC class I molecules on the output site are central in the MHC class I antigen presentation pathway and this review.

Mesh:

Substances:

Year:  2005        PMID: 16573239     DOI: 10.1007/3-540-28007-3_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  9 in total

Review 1.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

2.  Pronase E-Based Generation of Fluorescent Peptide Fragments: Tracking Intracellular Peptide Fate in Single Cells.

Authors:  Emilie R Mainz; Nicholas C Dobes; Nancy L Allbritton
Journal:  Anal Chem       Date:  2015-07-24       Impact factor: 6.986

3.  Structural arrangement of the transmission interface in the antigen ABC transport complex TAP.

Authors:  Giani Oancea; Megan L O'Mara; W F Drew Bennett; D Peter Tieleman; Rupert Abele; Robert Tampé
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

4.  Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects.

Authors:  Hyun-Il Cho; Esteban Celis
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

5.  Reconstruction of a pathway of antigen processing and class II MHC peptide capture.

Authors:  Catherine X Moss; Timothy I Tree; Colin Watts
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

6.  Molecular detection of targeted major histocompatibility complex I-bound peptides using a probabilistic measure and nanospray MS3 on a hybrid quadrupole-linear ion trap.

Authors:  Bruce Reinhold; Derin B Keskin; Ellis L Reinherz
Journal:  Anal Chem       Date:  2010-10-08       Impact factor: 6.986

7.  Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.

Authors:  Francesca Parolini; Priscilla Biswas; Michela Serena; Francesca Sironi; Valentina Muraro; Elisabetta Guizzardi; Lucia Cazzoletti; Maria Teresa Scupoli; Davide Gibellini; Elisabetta Ugolotti; Roberto Biassoni; Alberto Beretta; Mauro Malnati; Maria Grazia Romanelli; Donato Zipeto
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

Review 8.  Interferons at age 50: past, current and future impact on biomedicine.

Authors:  Ernest C Borden; Ganes C Sen; Gilles Uze; Robert H Silverman; Richard M Ransohoff; Graham R Foster; George R Stark
Journal:  Nat Rev Drug Discov       Date:  2007-12       Impact factor: 84.694

9.  HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation.

Authors:  Yang Yang; Weiyong Liu; Dan Hu; Rui Su; Man Ji; Yuqing Huang; Muhammad Adnan Shereen; Xiaodi Xu; Zhen Luo; Qi Zhang; Fang Liu; Kailang Wu; Yingle Liu; Jianguo Wu
Journal:  mBio       Date:  2020-10-27       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.